Cargando…
Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides
Distinguishing tumor recurrence from radiation necrosis following brain tumor therapy remains a major clinical challenge. Here we demonstrate the ability to distinguish these lesions using the amide proton transfer (APT) MRI signals of endogenous cellular proteins and peptides as an imaging biomarke...
Autores principales: | Zhou, Jinyuan, Tryggestad, Erik, Wen, Zhibo, Lal, Bachchu, Zhou, Tingting, Grossman, Rachel, Wang, Silun, Yan, Kun, Fu, De-Xue, Ford, Eric, Tyler, Betty, Blakeley, Jaishri, Laterra, John, van Zijl, Peter C.M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058561/ https://www.ncbi.nlm.nih.gov/pubmed/21170048 http://dx.doi.org/10.1038/nm.2268 |
Ejemplares similares
-
Dynamic Glucose-Enhanced (DGE) MRI: Translation to Human Scanning and First Results in Glioma Patients
por: Xu, Xiang, et al.
Publicado: (2015) -
SYST-12 LP-184, A NOVEL ACYLFULVENE-DERIVED TUMOR SITE ACTIVATED SMALL MOLECULE INHIBITS ADULT AND PEDIATRIC CNS TUMOR CELL GROWTH
por: Kulkarni, Aditya, et al.
Publicado: (2023) -
Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity
por: Sun, Peng, et al.
Publicado: (2014) -
EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase
por: Wang, Shervin D., et al.
Publicado: (2012) -
Learning-based analysis of amide proton transfer-weighted MRI to identify true progression in glioma patients
por: Guo, Pengfei, et al.
Publicado: (2022)